Sonofusion

Company Overview

Snapshot

Founded in November 2025, Sonofusion operates with 1–10 employees and is currently in the Pre-Funding stage. The company holds a patent for its technology, indicating a focus on proprietary innovation in the medical device sector.

Business overview

Sonofusion is developing a medical technology platform for non-invasive ultrasound surgery. Its core product is a proprietary system that combines histotripsy and thermal ablation to precisely target and destroy tumors and other pathologies without requiring incisions or ionizing radiation. This approach aims to improve clinical outcomes, shorten recovery times, and expand access to advanced therapies in both hospital and outpatient settings. The company focuses on oncology and other indications where focused ultrasound can replace or complement conventional surgical and radiotherapy procedures, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.

Company Intelligence Q&A

What is Sonofusion's primary focus?

Sonofusion focuses on developing a non-invasive ultrasound surgery platform for precise tumor treatment, utilizing a proprietary system that combines histotripsy and thermal ablation.

When was Sonofusion founded?

Sonofusion was founded in November 2025.

What is the current employee size of Sonofusion?

Sonofusion currently has 1–10 employees.

In which sector does Sonofusion primarily operate?

Sonofusion operates primarily in the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Treatment & Therapeutics.

What is the current product stage of Sonofusion's technology?

Sonofusion's product is currently in the Clinical Trial stage, indicating it is undergoing testing to evaluate its safety and efficacy in humans.